Phase 2 Extensive-stage Small-cell Lung Cancer Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
Extensive-stage Small-cell Lung Cancer
Second Hospital of Shanxi Medical University40 enrolled6 locationsNCT06536868
Recruiting
Phase 2
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
Liver MetastasesExtensive-stage Small-cell Lung Cancer
Kamya Sankar39 enrolled3 locationsNCT05588388
Recruiting
Phase 2
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.66 enrolled1 locationNCT06437509
Recruiting
Phase 2
First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy
Extensive-stage Small-cell Lung Cancer
Henan Cancer Hospital47 enrolled1 locationNCT06586697
Recruiting
Phase 2
Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC
Extensive-stage Small-cell Lung Cancer
Sichuan University61 enrolled8 locationsNCT05765825
Recruiting
Phase 1Phase 2
Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC
Lung CancerExtensive-stage Small-cell Lung Cancer
Sichuan University45 enrolled1 locationNCT06217757
Recruiting
Phase 2
Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC
Extensive-stage Small-cell Lung Cancer
Universität des Saarlandes43 enrolled5 locationsNCT06223711